/Companies

Adulsa Therapeutics

Berwyn, US · Founded 2020 · Delaware corporation

Find your way into Adulsa Therapeutics

Sign up to see every warm intro you have to Adulsa Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Adulsa Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

AM
Andrew MorozovNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$525K disclosed across 1 round · 2021

▶$525KraisedOct 2021 · 2 investors · Biotechnology
Officers, directors & promoters on the filing
  • Andrew MorozovExecutive Officer
Offering amount
$3.5M
Amount sold
$525K
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
04
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Adulsa Therapeutics raised?
Adulsa Therapeutics has disclosed $525K raised across 1 round.
Where is Adulsa Therapeutics headquartered?
Adulsa Therapeutics is headquartered in Berwyn, US.